Cancer Research Meeting Calendar  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cui, H.
Right arrow Articles by Feinberg, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cui, H.
Right arrow Articles by Feinberg, A. P.
[Cancer Research 61, 4947-4950, July 1, 2001]
© 2001 American Association for Cancer Research


Advances in Brief

Loss of Imprinting of Insulin-like Growth Factor-II in Wilms’ Tumor Commonly Involves Altered Methylation but not Mutations of CTCF or Its Binding Site1

Hengmi Cui, Emily L. Niemitz, Jason D. Ravenel, Patrick Onyango, Sheri A. Brandenburg, Victor V. Lobanenkov and Andrew P. Feinberg2

Institute of Genetic Medicine [H. C., E. L. N., J. D. R., P. O., S. A. B., A. P. F.] and Departments of Medicine [H. C., A. P. F.], Oncology [A. P. F.], and Molecular Biology and Genetics [A. P. F.], Graduate Programs in Human Genetics [E. L. N.], and Biochemistry, Cell and Molecular Biology [J. D. R.], Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, and National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892 [V. V. L.]

Loss of imprinting (LOI) is the most common molecular abnormality in Wilms’ tumor (WT), other embryonal cancers, and most other tumor types. LOI in WT involves activation of the normally silent maternal allele of the insulin-like growth factor-II (IGF2) gene, silencing of the normally active maternal allele of the H19 gene, and aberrant methylation of a differentially methylated region (DMR) upstream of the maternal copy of H19. Recently, the transcription factor CTCF, which binds to the H19 DMR, has been implicated in the maintenance of H19 and IGF2 imprinting. Here, we show that mutations in the CTCF gene or in the H19 DMR do not occur at significant frequency in WT, nor is there transcriptional silencing of CTCF. We also confirm that methylation of the H19 DMR in WT with LOI includes the CTCF core consensus site. However, some WTs with normal imprinting of IGF2 also show aberrant methylation of CTCF binding sites, indicating that methylation of these sites is necessary but not sufficient for LOI in WT.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
P. J. Beltran, P. Mitchell, Y.-A Chung, E. Cajulis, J. Lu, B. Belmontes, J. Ho, M. M. Tsai, M. Zhu, S. Vonderfecht, et al.
AMG 479, a fully human anti-insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells
Mol. Cancer Ther., May 1, 2009; 8(5): 1095 - 1105.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. X. Fu, J. R. Dobosy, J. A. Desotelle, N. Almassi, J. A. Ewald, R. Srinivasan, M. Berres, J. Svaren, R. Weindruch, and D. F. Jarrard
Aging and Cancer-Related Loss of Insulin-like Growth Factor 2 Imprinting in the Mouse and Human Prostate
Cancer Res., August 15, 2008; 68(16): 6797 - 6802.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. T. Bjornsson, M. I. Sigurdsson, M. D. Fallin, R. A. Irizarry, T. Aspelund, H. Cui, W. Yu, M. A. Rongione, T. J. Ekstrom, T. B. Harris, et al.
Intra-individual Change Over Time in DNA Methylation With Familial Clustering
JAMA, June 25, 2008; 299(24): 2877 - 2883.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
F. Cerrato, A. Sparago, G. Verde, A. De Crescenzo, V. Citro, M. V. Cubellis, M. M. Rinaldi, L. Boccuto, G. Neri, C. Magnani, et al.
Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour
Hum. Mol. Genet., May 15, 2008; 17(10): 1427 - 1435.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H.-M. Byun, H.-L. Wong, E. A. Birnstein, E. M. Wolff, G. Liang, and A. S. Yang
Examination of IGF2 and H19 Loss of Imprinting in Bladder Cancer
Cancer Res., November 15, 2007; 67(22): 10753 - 10758.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. L. Hancock, K. W. Brown, K. Moorwood, H. Moon, C. Holmgren, S. H. Mardikar, A. R. Dallosso, E. Klenova, D. Loukinov, R. Ohlsson, et al.
A CTCF-binding silencer regulates the imprinted genes AWT1 and WT1-AS and exhibits sequential epigenetic defects during Wilms' tumourigenesis
Hum. Mol. Genet., February 1, 2007; 16(3): 343 - 354.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. Tost, H. Jammes, J.-M. Dupont, C. Buffat, B. Robert, T.-M. Mignot, F. Mondon, B. Carbonne, U. Simeoni, G. Grange, et al.
Non-random, individual-specific methylation profiles are present at the sixth CTCF binding site in the human H19/IGF2 imprinting control region
Nucleic Acids Res., November 14, 2006; 34(19): 5438 - 5448.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
S. K. Murphy, Z. Huang, Y. Wen, M. A. Spillman, R. S. Whitaker, L. R. Simel, T. D. Nichols, J. R. Marks, and A. Berchuck
Frequent IGF2/H19 Domain Epigenetic Alterations and Elevated IGF2 Expression in Epithelial Ovarian Cancer
Mol. Cancer Res., April 1, 2006; 4(4): 283 - 292.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
R. A. Waterland, J.-R. Lin, C. A. Smith, and R. L. Jirtle
Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus
Hum. Mol. Genet., March 1, 2006; 15(5): 705 - 716.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. G. West and P. Fraser
Remote control of gene transcription
Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R101 - R111.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Prawitt, T. Enklaar, B. Gartner-Rupprecht, C. Spangenberg, M. Oswald, E. Lausch, P. Schmidtke, D. Reutzel, S. Fees, R. Lucito, et al.
Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor
PNAS, March 15, 2005; 102(11): 4085 - 4090.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. X. Fu, S. R. Schwarze, M. L. Kenowski, S. LeBlanc, J. Svaren, and D. F. Jarrard
A Loss of Insulin-like Growth Factor-2 Imprinting Is Modulated by CCCTC-binding Factor Down-regulation at Senescence in Human Epithelial Cells
J. Biol. Chem., December 10, 2004; 279(50): 52218 - 52226.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. T.C. Chan, Q. Tao, K. D. Robertson, I. W. Flinn, R. B. Mann, B. Klencke, W. H. Kwan, T. W.-T. Leung, P. J. Johnson, and R. F. Ambinder
Azacitidine Induces Demethylation of the Epstein-Barr Virus Genome in Tumors
J. Clin. Oncol., April 15, 2004; 22(8): 1373 - 1381.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. A. Ulaner, Y. Yang, J.-F. Hu, T. Li, T. H. Vu, and A. R. Hoffman
CTCF Binding at the Insulin-Like Growth Factor-II (IGF2)/H19 Imprinting Control Region Is Insufficient to Regulate IGF2/H19 Expression in Human Tissues
Endocrinology, October 1, 2003; 144(10): 4420 - 4426.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
G. A. Ulaner, T. H. Vu, T. Li, J.-F. Hu, X.-M. Yao, Y. Yang, R. Gorlick, P. Meyers, J. Healey, M. Ladanyi, et al.
Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site
Hum. Mol. Genet., March 1, 2003; 12(5): 535 - 549.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Ishizaki, M. Yoshie, Y. Yaginuma, T. Tanaka, and K. Ogawa
Loss of Igf2 Imprinting in Monoclonal Mouse Hepatic Tumor Cells Is Not Associated with Abnormal Methylation Patterns for the H19, Igf2, and Kvlqt1 Differentially Methylated Regions
J. Biol. Chem., February 14, 2003; 278(8): 6222 - 6228.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. S. Tam, T. R. Devereux, A. C. Patel, J. F. Foley, R. R. Maronpot, and T. E. Massey
Perturbations of the Ink4a/Arf gene locus in aflatoxin B1-induced mouse lung tumors
Carcinogenesis, January 1, 2003; 24(1): 121 - 132.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Cui, P. Onyango, S. Brandenburg, Y. Wu, C.-L. Hsieh, and A. P. Feinberg
Loss of Imprinting in Colorectal Cancer Linked to Hypomethylation of H19 and IGF2
Cancer Res., November 15, 2002; 62(22): 6442 - 6446.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. P. Feinberg, M. Oshimura, and J. C. Barrett
Epigenetic Mechanisms in Human Disease
Cancer Res., November 15, 2002; 62(22): 6784 - 6787.
[Full Text] [PDF]


Home page
Cancer Res.Home page
C. Kanduri, M. Kanduri, L. Liu, N. Thakur, S. Pfeifer, and R. Ohlsson
The Kinetics of Deregulation of Expression by de Novo Methylation of the H19 Imprinting Control Region in Cancer Cells
Cancer Res., August 15, 2002; 62(16): 4545 - 4548.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Onyango, S. Jiang, H. Uejima, M. J. Shamblott, J. D. Gearhart, H. Cui, and A. P. Feinberg
Monoallelic expression and methylation of imprinted genes in human and mouse embryonic germ cell lineages
PNAS, August 6, 2002; 99(16): 10599 - 10604.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Z.-H. Gao, S. Suppola, J. Liu, P. Heikkila, J. Janne, and R. Voutilainen
Association of H19 Promoter Methylation with the Expression of H19 and IGF-II Genes in Adrenocortical Tumors
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1170 - 1176.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Stimson and P. M. Vertino
Methylation-mediated Silencing of TMS1/ASC Is Accompanied by Histone Hypoacetylation and CpG Island-localized Changes in Chromatin Architecture
J. Biol. Chem., February 8, 2002; 277(7): 4951 - 4958.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
K. Davies, L. Bowden, P. Smith, W. Dean, D. Hill, H. Furuumi, H. Sasaki, B. Cattanach, and W. Reik
Disruption of mesodermal enhancers for Igf2 in the minute mutant
Development, January 4, 2002; 129(7): 1657 - 1668.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. T. Schneider, A. E. Schuster, M. K. Fritsch, J. Hu, T. Olson, S. Lauer, U. Gobel, and E. J. Perlman
Multipoint Imprinting Analysis Indicates a Common Precursor Cell for Gonadal and Nongonadal Pediatric Germ Cell Tumors
Cancer Res., October 1, 2001; 61(19): 7268 - 7276.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.